🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Linda Cao

University of North Carolina at Chapel Hill

ORCID: 0000-0002-5916-1314

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti–PD-1 immunotherapy”.

Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti–PD-1 immunotherapy

Science Translational Medicine(2022)10.1126/scitranslmed.abq7019

N/A

0.606DataRank · unranked

56 citations

Nagendra Yarla, Tarek Haykal, Y‐Van Nguyen, Linda Cao, Michelle Ferreira +8 more

Overcoming Immunotherapy Resistance by Targeting the Tumor-Intrinsic NLRP3-HSP70 Signaling Axis

Cancers(2021)10.3390/cancers13194753

N/A

0DataRank · unranked

18 citations

Tarek Haykal, Linda Cao, Alisha Holtzhausen, Michael P. Plebanek, Nicholas C. DeVito +2 more

Tumor NLRP3 Amplification Promotes Immunotherapy Resistance by Suppressing MHC Class I Expression

medRxiv(2025)10.1101/2025.10.06.25337175

N/A

0DataRank · unranked

0 citations

Nagendra Sastry Yarla, Kaylee Villareal, Y‐Van Nguyen, Linda Cao, Ernesto Pena Calderin +9 more